Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Abrdn Physical Platinum Shares ETF (PPLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Abrdn Physical Platinum Shares ETF — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.27 (market cap $12.58B), while Abrdn Physical Platinum Shares ETF trades at $15.26 (market cap $1.93B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 6.5× Abrdn Physical Platinum Shares ETF's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Abrdn Physical Platinum Shares ETF for 42 Days on average.
| HALO | PPLT | |
|---|---|---|
Market Cap | $12.58B | $1.93B |
Volume | 2,179,278 | 1,698,523 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $115.22 | $25.23 |
52-Week Low | $61.63 | $13.73 |
Typical Hold Time | 1 Days | 42 Days |
Enterprise Value | $14.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PPLT, the abrdn Physical Platinum Shares ETF, trades at $14.78, down 4.46% today, reflecting a bearish technical outlook with moving averages and oscillators signaling sell pressure. Recent news highlights platinum's underperformance versus other precious metals, with the term structure in contango suggesting adequate supply. Key financial ratios are unavailable in the provided data, limiting fundamental assessment.
The outlook remains cautious due to weak technical signals and platinum's lag in the metals rally, though historical seasonality may offer contrarian hope. Risks include commodity price volatility and supply-demand dynamics. Investors should await updated financials for a clearer fundamental picture amid current bearish sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Abrdn Physical Platinum Shares ETF
PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →
